https://www.selleckchem.com/pr....oducts/tipranavir.ht
The two study groups were comparable in terms of age, sex, ISS, TRISS, and the number of LTOWB transfused. The use of LR LTOWB during the initial massive transfusion activation in traumatically injured patients was not associated with increased 24-hour survival compared to when using non-LR LTOWB. No transfusion associated adverse events were reported. The administration of either LR or non-LR LTOWB was not associated with 24 hours survival in patients presenting with massive hemorrhage. The high cost and the rapid decline in pla
Like
Comment
Share
